The FDA granted emergency use authorization to a test that bucks those norms: a 15-minute PCR test, developed by researchers from Chicago-based Northwestern University’s Feinberg School of Medicine and Northwestern’s McCormick School of Engineering in Evanston, Ill., according to a news release.
The test, called the Diagnostic Analyzer for Specific Hybridization, is packaged in a device that’s about the size of a cereal box, the news release said. Users perform a single nasal swab, insert it into the device, and 15 minutes later a positive or negative result appears on the device’s touchscreen.
“DASH offers the accuracy of other PCR tests in a compact, portable platform that can be operated by non-technical personnel at the point-of-care in 15 minutes,” researcher Robert Murphy, MD, said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
